Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

2.8K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.8K
Neural Regulation01:37

Neural Regulation

44.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Long-term Depression01:03

Long-term Depression

3.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

5-HT<sub>6</sub> Receptors Control GABAergic Transmission and CA1 Pyramidal Cell Output of Dorsal Hippocampus.

Neuroscience·2023
Same author

Activation of 5-HT<sub>1A</sub> and 5-HT<sub>7</sub> receptors enhanced a positively reinforced long-term memory.

Behavioural brain research·2020
Same author

Editorial: Neuropharmacological, Neurobiological and Behavioral Mechanisms of Learning and Memory.

Frontiers in pharmacology·2019
Same author

Copolymer-1 enhances cognitive performance in young adult rats.

PloS one·2018
Same author

Frameworking memory and serotonergic markers.

Reviews in the neurosciences·2017
Same author

Corrigendum: Editorial: Serotonin and Memory.

Frontiers in pharmacology·2016

Related Experiment Video

Updated: Mar 10, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.8K

Neural activity, memory, and dementias: serotonergic markers.

Alfredo Meneses1

  • 1Pharmacobiology Departament, CINVESTAV. Mexico City, Mexico.

Behavioural Pharmacology
|December 8, 2016
PubMed
Summary

Memory dysfunction in dementia may be treatable by targeting serotonin pathways. Neural markers like serotonin receptors and transporters offer potential therapeutic targets for improving memory and cognitive function.

More Related Videos

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

3.8K
Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain
09:25

Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain

Published on: May 21, 2019

7.3K

Related Experiment Videos

Last Updated: Mar 10, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.8K
A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

3.8K
Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain
09:25

Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain

Published on: May 21, 2019

7.3K

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Memory dysfunction is a core symptom of dementias and neuropsychiatric disorders.
  • Effective treatments are lacking due to the absence of reliable neural biomarkers.
  • The serotonin (5-hydroxytryptamine or 5-HT) system is implicated in memory processes.

Purpose of the Study:

  • To explore the role of the serotonin system as a source of neural biomarkers for memory dysfunction.
  • To identify potential therapeutic targets within the serotonin system for treating memory deficits.

Main Methods:

  • Review of existing literature on serotonergic mechanisms in memory.
  • Analysis of neural markers, including serotonin receptors (5-HT1-7) and transporters.
  • Examination of the bidirectional relationship between memory processes and serotonergic markers.

Main Results:

  • Serotonin receptors (e.g., 5-HT1A, 5-HT4, 5-HT6, 5-HT7) and the serotonin transporter are present in memory-related brain areas.
  • These markers are altered by memory, amnesia, and forgetting.
  • Specific receptors (5-HT2A/2B/2C, 5-HT4, 5-HT6) are linked to tau hyperphosphorylation in Alzheimer's disease.

Conclusions:

  • Serotonergic neural markers represent promising targets for therapeutic intervention in memory disorders.
  • Modulating the serotonin system may offer a strategy to reverse or reduce memory deficits in dementia.
  • Synaptic plasticity, crucial for memory, involves changes in neurotransmitter receptors and transporters.